Key result
Classical growth hormone deficiency was associated with significantly lower serum IGFBP-3 levels compared to healthy controls during both prepuberty (P<0.001) and puberty (P<0.05).
Why the study?
Does serum IGFBP-3 measurement using Western Ligand Blot assay differentiate patients with classical growth hormone deficiency from healthy controls?
Cross-Sectional (n=68)
Does serum IGFBP-3 measurement using Western Ligand Blot assay differentiate patients with classical growth hormone deficiency from healthy controls?
Measurement of serum IGFBP-3 using Western Ligand Blot assay is a useful diagnostic marker for classical growth hormone deficiency, especially before puberty.
Answers are grounded in this paper and cite their sources.
Lower IGFBP-3 levels may support diagnostic utility in GHD; leaves open clinical adoption pending prospective validation.
The insulin-like growth factors I and II (IGFs), important growth factors both in vivo and in vitro, are known to have at least six binding proteins (IGFBP-1-6). In human serum, IGFBP-3 is a major binding protein and is considered to be GH-IGF-I-dependent. We have established a Western Ligand Blot (WLB) assay for IGFBP-3. The method is a densitometric analysis of IGFBP-3 bands on a film of WLB. The IGFBP-3 levels of patients with classical growth hormone deficiency (GHD, 5 isolated and 10 multiple hormone deficiencies with appropriate therapy) were studied. Before puberty there is no overlap between control (n = 31) and the patients with GHD (n = 10). However, IGFBP-3 levels of two of five pubertal patients with GHD were within the normal range (n = 16). We think that measurement of serum IGFBP-3 is a useful diagnostic marker for GHD, especially before puberty.
No takes yet. Share an insight, caveat, or question.
Hasegawa et al. (1992) conducted a cross-sectional in Classical Growth Hormone Deficiency (n=68). Classical Growth Hormone Deficiency vs. Healthy controls was evaluated on Serum IGFBP-3 levels expressed as a percentage of adult pooled control serum (BP-3-D%) (p=<0.001). Classical growth hormone deficiency was associated with significantly lower serum IGFBP-3 levels compared to healthy controls during both prepuberty (P<0.001) and puberty (P<0.05).
Synapse has enriched 10 related papers. Consider them for comparative context: